Inventor · disambiguated record
Nigel R. A. Beeley
Also filed as: BEELEY NIGEL R · BEELEY NIGEL R A
24 granted patents·5 pending applications·488 citations·filing 1999–2022
96Inventor score
Files withELCELYX THERAPEUTICS INC10BARON ALAIN D6ANJI PHARMA US LLC4AMYLIN PHARMACEUTICALS INC3ANJI PHARMACEUTICALS INC2
Top patents by PatentIndex Score
29 records- 0198US7928065B2Methods of treatment using exendin peptides or GLP-1 peptidesAMYLIN PHARMACEUTICALS INC·Filed 2008·Granted Apr 19, 2011·63 cites·45 claims
- 0297US9211263B2Compositions and methods of treating metabolic disordersELCELYX THERAPEUTICS INC·Filed 2013·Granted Dec 15, 2015·24 cites·8 claims
- 0396US10610500B2Chemosensory receptor ligand-based therapiesANJI PHARMA US LLC·Filed 2018·Granted Apr 7, 2020·8 cites·41 claims
- 0496US7442680B2Inotropic and diuretic effects of GLP-1 and GLP-1 agonistsAMYLIN PHARMACEUTICALS INC·Filed 2003·Granted Oct 28, 2008·66 cites·16 claims
- 0596US6703359B1Inotropic and diuretic effects of exendin and GLP-1AMYLIN PHARMACEUTICALS INC·Filed 1999·Granted Mar 9, 2004·160 cites·42 claims
- 0695US10028923B2Biguanide compositions and methods of treating metabolic disordersELCELYX THERAPEUTICS INC·Filed 2016·Granted Jul 24, 2018·9 cites·26 claims
- 0795US9962344B2Chemosensory receptor ligand-based therapiesELCELYX THERAPEUTICS INC·Filed 2016·Granted May 8, 2018·14 cites·24 claims
- 0895US9481642B2Biguanide compositions and methods of treating metabolic disordersELCELYX THERAPEUTICS INC·Filed 2014·Granted Nov 1, 2016·14 cites·25 claims
- 0995US9463170B2Chemosensory receptor ligand-based therapiesELCELYX THERAPEUTICS INC·Filed 2015·Granted Oct 11, 2016·15 cites·35 claims
- 1095US8796338B2Biguanide compositions and methods of treating metabolic disordersBARON ALAIN D·Filed 2012·Granted Aug 5, 2014·27 cites·14 claims
- 1194US10159658B2Compositions comprising statins, biguanides and further agents for reducing cardiometabolic riskELCELYX THERAPEUTICS INC·Filed 2017·Granted Dec 25, 2018·8 cites·29 claims
- 1294US9770422B2Compositions and methods for treating metabolic disordersELCELYX THERAPEUTICS INC·Filed 2015·Granted Sep 26, 2017·7 cites·23 claims
- 1393US10603291B2Compositions and methods for treating metabolic disordersANJI PHARMA US LLC·Filed 2017·Granted Mar 31, 2020·5 cites·30 claims
- 1493US9050292B2Chemosensory receptor ligand-based therapiesBARON ALAIN D·Filed 2012·Granted Jun 9, 2015·24 cites·25 claims
- 1592US10668031B2Biguanide compositions and methods of treating metabolic disordersANJI PHARMA US LLC·Filed 2018·Granted Jun 2, 2020·6 cites·24 claims
- 1692US10154972B2Biguanide compositions and methods of treating metabolic disordersELCELYX THERAPEUTICS INC·Filed 2016·Granted Dec 18, 2018·10 cites·27 claims
- 1792US9572784B2Compositions comprising statins, biguanides and further agents for reducing cardiometabolic riskELCELYX THERAPEUTICS INC·Filed 2013·Granted Feb 21, 2017·7 cites·23 claims
- 1891US9480663B2Biguanide compositions and methods of treating metabolic disordersBARON ALAIN D·Filed 2012·Granted Nov 1, 2016·8 cites·27 claims
- 1988US10201511B2Compositions and methods for treating metabolic disordersELCELYX THERAPEUTICS INC·Filed 2013·Granted Feb 12, 2019·8 cites·39 claims
- 2083US11065215B2Biguanide compositions and methods of treating metabolic disordersANJI PHARMA US LLC·Filed 2018·Granted Jul 20, 2021·3 cites·23 claims
- 2175US8759291B2Methods of treatment using exendin peptides or GLP-1 peptidesYOUNG ANDREW A·Filed 2011·Granted Jun 24, 2014·2 cites·15 claims
- 2258US11759441B2Biguanide compositions and methods of treating metabolic disordersANJI PHARMACEUTICALS INC·Filed 2021·Granted Sep 19, 2023·0 cites·13 claims
- 2358US2024307363A1Methods for treating a pulmonary disease with an alk-5 (tgf beta r1) inhibitorTHIRONA BIO INC·Filed 2022·Application pending·0 cites
- 2452US11974971B2Compositions and methods for treating metabolic disordersANJI PHARMACEUTICALS INC·Filed 2019·Granted May 7, 2024·0 cites·7 claims
- 2550US11865113B2Methods of treating a patient afflicted with non-alcoholic steatohepatitis (NASH)LIPIDIO PHARMACEUTICALS INC·Filed 2017·Granted Jan 9, 2024·0 cites·9 claims
- 2637US2013281387A1Chemosensory Receptor Ligand-Based TherapiesBARON ALAIN D·Filed 2011·Application pending·0 cites
- 2737US2013303466A1Chemosensory Receptor Ligand-Based TherapiesBROWN MARTIN R·Filed 2011·Application pending·0 cites
- 2837US2013281394A1Chemosensory Receptor Ligand-Based TherapiesBARON ALAIN D·Filed 2011·Application pending·0 cites
- 2937US2013338095A1Chemosensory Receptor Ligand-Based TherapiesBARON ALAIN D·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nigel R. A. Beeley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →